Ozempic Rival Delivers 25% Weight Loss at Highest Dose in Phase 3 Trial
Favicon 
www.sciencealert.com

Ozempic Rival Delivers 25% Weight Loss at Highest Dose in Phase 3 Trial

(rostislavsedlacek/Canva) A weekly injection, striking results.ScienceAlert stories are written, fact-checked, and edited by humans, never generated by AI. Don't miss a story, subscribe here.